Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01226329 · ClinicalTrials.gov registry record · NA

The Right Question Project-Mental Health: An Intervention to Increase Engagement and Retention in Mental Health Care

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
724
Enrollment target

NCT01226329: Completed NA study, sponsored by Massachusetts General Hospital.

NCT01226329 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 724 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (48% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01226329, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
724 participants
Enrollment target

Study Summary

The Right Question Project-Mental Health (RQP-MH) is a three-session health education intervention that teaches clients to participate effectively in mental health care. The methodology teaches clients to identify important issues of their illness or treatment, formulate questions, and devise plans to communicate and act in effective ways that address factors impacting their mental health care, with the expectation that this behavior will increase patient-provider communication and improve the therapeutic alliance between patient and provider. The investigators hypothesize that participants receiving the intervention will be more likely to engage and remain in mental health care, and that they will report higher activation and self-management scores as compared to control patients.

Primary Outcome

Activation is defined as a behavior change approach that includes an individual's acquisition of knowledge, skills and beliefs to take thoughtful action on one's own behalf and actively participate in questions and decisions about one's health and health care treatment.

Interventions

  • BEHAVIORAL Pamphlet
  • BEHAVIORAL Right Question Project - Mental Health (RQP-MH)

Trial Details

FieldValue
Enrollment Target 724 participants
Start Date 2008-07
Est. Completion 2011-10
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT01226329 record still lists

NCT01226329 is an interventional study that assigns participants to a tested intervention. The registered 724 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (48% lower).

The record links to 0 conditions, and to 2 interventions - of which Pamphlet is the first listed.

NCT01226329 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01226329 about?

NCT01226329 is a clinical study titled "The Right Question Project-Mental Health: An Intervention to Increase Engagement and Retention in Mental Health Care". The Right Question Project-Mental Health (RQP-MH) is a three-session health education intervention that teaches clients to participate effectively in mental health care. The methodology teaches clients to identify important issues of their illness or treatment, formulate questions, and devise plans ...

What is the current status of trial NCT01226329?

This trial is currently completed. It is a NA study. The enrollment target is 724 participants. The study started on 2008-07. Estimated completion is 2011-10.

What interventions are being tested in trial NCT01226329?

The interventions under investigation include: Pamphlet (BEHAVIORAL), Right Question Project - Mental Health (RQP-MH) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01226329?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01226329's enrollment target sits among peer trials

724 145th of 2000 higher than 1,856 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06664619 · 724 participants · Phase 3

    A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

  • NCT05634967 · 725 participants

    Kesimpta (Ofatumumab) Pregnancy Registry

  • NCT06641466 · 723 participants · Phase 3

    A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

  • NCT07088068 · 723 participants · Phase 3

    A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01226329, the US trial registry maintained by the National Library of Medicine. NCT01226329 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.